1. Complement System: Promoter or Suppressor of Cancer Progression?
   Margot Revel et al, 2020, Antibodies CrossRef
2. Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
   Chia-Chi Liu et al, 2022, Frontiers in Oncology CrossRef
3. FXYD-3 expression in relation to local recurrence of rectal cancer
   Per Loftas et al, 2016, Radiation Oncology Journal CrossRef
4. Les protéines FXYD : nouveaux régulateurs de la Na,K-ATPase
   Benjamin Delprat et al, 2006, médecine/sciences CrossRef
5. FXYD3 (Mat-8), a New Regulator of Na,K-ATPase
   Gilles Crambert et al, 2005, Molecular Biology of the Cell CrossRef
6. FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes
   Wenjuan Yang et al, 2023, Cellular & Molecular Immunology CrossRef
7. FXYD proteins and sodium pump regulatory mechanisms
   John Q. Yap et al, 2021, Journal of General Physiology CrossRef
8. PARK7 and Nucleoside Diphosphate Kinase A as Plasma Markers for the Early Diagnosis of Stroke
   Laure Allard et al, 2005, Clinical Chemistry CrossRef
9. FXYD proteins: new regulators of Na-K-ATPase
   Käthi Geering, 2006, American Journal of Physiology-Renal Physiology CrossRef